Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide with Thalidomide, Isotretinoin, and Celecoxib in Glioblastoma Multiforme
NCT00112502Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2005
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide, isotretinoin, celecoxib oral solution in glioblastoma multiforme (GBM), sponsored by University of Texas MD Anderson Cancer Center. Started Sep 2005; status: completed.
02
Drugs
thalidomideisotretinoincelecoxib oral solution
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00112502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112502.